can i take semaglutide if i have covid Obesity Drug Wegovy Prevents Deaths, Study Suggests GLP-1 Medications and COVID-19: Safety

Semaglutide works by: Reducing appetite by acting on receptors in the brain that control hunger and satiety Slowing gastric emptying , which helps you feel fuller for longer after meals Improving blood sugar regulation by enhancing insulin secretion when glucose levels are elevated Wegovy is administered as a once-weekly subcutaneous injection, typically starting at a low dose (0.25 mg) and gradually increasing over 16-20 weeks to the maintenance dose of 2.4 mg, as outlined in the Summary of Product Characteristics (SmPC)

By mimicking a hormone called glucagon-like peptide-1 (GLP-1), it regulates appetite, decreases food intake, and controls blood glucose levels

When activated, AMPK may enhance insulin sensitivity, increase glucose uptake in skeletal muscle, suppress hepatic gluconeogenesis, and improve lipid metabolism

Patients should disclose GLP-1 treatments obtained from private clinics or online providers because they may not automatically appear in NHS medical records